Category: Blackstone

Carbon Health raises $350M to further expansion plans

Blackstone, Carbon Health, Daily, funding, Health Tech, primary care, Startups, SYN, Top Story / July 22, 2021 July 22, 2021

After more than doubling its patient volumes during the pandemic, Carbon Health raised funding to further its growth plans. The company said it plans to open 1,500 clinics by 2025.

Anthem, K Health, Blackstone launch digital health company

Anthem, app, Blackstone, Consumers, Daily, Employers, Health IT, Health Tech, Joint Venture, K-Health, News, Payers, Symptom Checker, SYN, technology, Top Story / April 14, 2021 April 14, 2021

The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.

Imago raises $80M to further studies of its treatment for blood and bone-marrow disorders

Amgen Ventures, BioPharma, biopharma nl, Blackstone, blood cancer, bone marrow cancer drugs, Clarus Ventures, Daily, Farallon Capital Management, FDA, FerroKin BioSciences, frazier healthcare partners, Greenspring Associates, Highlight Capital, Imago BioSciences, Irving Investors, Kindgon Capital Management, MRL Ventures Fund, News, Omega Funds, Pharmaron Investments, Shire, Startups, Surveyor Capital, SYN, Top Story, Xeraya Capital / November 19, 2020 November 19, 2020

The San Francisco-based company aims to complete at least one Phase III study by 2025, and it is weighing an IPO next year to fund more.

Takeda agrees $2.3bn sale of Japanese consumer health unit

Blackstone, consumer healthcare, M&A, News, Sales and Marketing, Takeda / August 24, 2020 August 24, 2020

Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. The drugmaker is divesting Takeda Consumer Healthcare, which operates mainly in Japan, to private equity group Blackstone for 242 billion yen ($2.3 billion), with the deal expected to close in March of next year. …

Takeda agrees $2.3bn sale of Japanese consumer health unit Read More »

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

$2.3B, Blackstone, Consumer Health Unit, Divest, Japan, Pharma, Takeda / August 24, 2020 August 24, 2020

Shots: Takeda and Blackstone sign an agreement to divest it consumer health care business unit for $2.3B. The transaction expected to be closed by Mar 31, 2021 The portfolio to be divested includes OTC medicines and health products along with its lead product in the region, Alinamin. Blackstone plans to develop the business together with …

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan Read More »

Blackstone’s $4.7B acquisition of Ancestry raises privacy questions

ancestry, AncestryDNA, Blackstone, Daily, Health Services, Health Tech, Mergers and Acquisitions, privacy, SYN, Top Story / August 6, 2020 August 6, 2020

Ancestry, which grew from a genealogy tracking tool to offering DNA tests for a number of healthconditions, reached a deal to be acquired by Blackstone for $4.7 billion. But privacy advocates have raised concerns over the deal — namely, what would happen to users’ health data?